Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Trial on Long Responses in Patients With Advanced Non-Small Cell Lung Cancer Treated in Second-Line With Erlotinib

NCT02133508 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02133508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02133508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Trial on Long Responses in Patients With Advanced Non-Small Cell Lung Cancer Treated in Second-Line With Erlotinib
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
June 10, 2016
Enrollment
172 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer